Multiple myeloma-induced immune paresis is mainly attributed to the impairment of T-cell (CD4+, and CD8+) activation and proliferation, which is mediated by myeloma cell-induced production of transforming growth factor (TGFβ) [3, 12, 14]. This evidence concerns the gene CD4 and plasma cell myeloma.